Czech scientists successfully test potential lyme disease vaccine

In Hungary

Graphic by Double Brain / Shutterstock.com

Scientists from the Biology Center of the Czech Academy of Sciences in České Budějovice have successfully tested a potential new vaccine that could be used to treat lyme disease, reports Czech Radio. 

Graphic by Double Brain / Shutterstock.com

The treatment, developed by pharmaceutical researcher Sanofi, currently holds a 100% success rate in treating the illness. The results of the tests were published earlier this month in the NPJ Vaccines journal.

Lyme disease is an illness transferred by ticks. In the Czech Republic alone, around 4,000 people a year are diagnosed with the sickness, Czech Radio says.

Hungary CPI Drop Acknowledged at IMF/World Bank Spring Meeti... Figures

Hungary CPI Drop Acknowledged at IMF/World Bank Spring Meeti...

Hungary to Address Future of Cohesion Policy During EU Presi... EU

Hungary to Address Future of Cohesion Policy During EU Presi...

2/3 of Hungarians Have Basic Expectation of Home Office HR

2/3 of Hungarians Have Basic Expectation of Home Office

Time Out Market to Open in Budapest Next Year Food

Time Out Market to Open in Budapest Next Year

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.